Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

RSV infections lead to 640,000 antibiotic prescriptions a year

RSV infections lead to 640,000 antibiotic prescriptions a year

Around 2.1% of antibiotic prescriptions in English GPs were linked to RSV infections. 

Experts suggest that the new Respiratory Syncytial Virus (RSV) vaccination programme, being rolled out in hospitals and community pharmacies, will not only reduce the burden of RSV infections in England but also contribute to a reduction in antibiotic prescriptions.

While antibiotics are ineffective against viruses, they are sometimes prescribed in primary care because it is difficult to distinguish between bacterial and viral infections.


A study conducted by the UK Health Security Agency (UKHSA), Imperial College London, and Oxford Population Health revealed that RSV infections result in 640,000 antibiotic prescriptions a year.

The study suggests that interventions to reduce RSV infections, including the new vaccine programme, could lower antibiotic use and, in turn, reduce antibiotic resistance.

RSV typically causes mild respiratory symptoms in most individuals, but it can lead to serious illness and hospitalisation in vulnerable groups, such as infants and older adults.

The research team analysed data from general practice antibiotic prescriptions and laboratory-confirmed respiratory infections between 2015 and 2018.

They found that approximately 2.1% of antibiotic prescriptions in English GPs were linked to RSV infections, with the highest number prescribed to those over 75 and infants.

Dr. Lucy Miller, a co-author of the study and Modeller at UKHSA, stressed the importance of reducing antibiotic use to address antibiotic resistance.

“To tackle antibiotic resistance we need to ensure antibiotics are being used only when necessary. But we also need to drive down infections, to reduce the need for antibiotics in the first place.

“This study highlights that the introduction of the new RSV vaccine programme could not only help reduce the risk of infections in vulnerable individuals, but also contribute towards a reduction in antibiotic prescribing and antibiotic resistance in the population overall,” she said.

Launched in September, the new RSV vaccination programme targets pregnant women and adults aged 75 and over. Analysis predicts that the programme could prevent 70,000 RSV illnesses in infants under 12 months and 60,000 illnesses in eligible older adults.

Steve Russell, NHS national director for vaccinations and screening, urged eligible people to take the vaccine.

“This research is a step-forward in demonstrating the impact the RSV vaccine can have, over and above preventing tens of thousands of fewer illnesses this year in those most at risk, so please do take up the offer of the jab if you are aged 75 to 79 or if you are over 28 weeks pregnant – it could prevent you or your baby from becoming seriously ill.”

The research, which was funded by the Medical Research Foundation and the National Institute for Health and Care Research, has been published as a preprint.

More For You

A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less
Patients to get test results via NHS app

An investment of £50m has been made to upgrade the NHS app

Patients to get test results via NHS app

Millions of patients will now be able to access test results and get appointment reminders on their smartphones as the government tries to position the NHS app as the default mode of communication and steer away from traditional methods like letters.

An investment of £50m has been made to upgrade the NHS app and the health service hopes to save £200m over the next three years.

Keep ReadingShow less
Health minister assures House of Lords on measures to tackle UK-wide Creon drug shortage

Baroness Merron

Government taking steps to mitigate shortage of cancer drug Creon

Baroness Merron on Monday (9) assured the House of Lords that the government is taking measures to mitigate the shortage of pancreatic cancer drug Creon across the country.

Raising the issue, Baroness Margaret Ritchie wanted to know about the steps being taken by the government to ease the misery of patients suffering from pancreatic cancer.

Keep ReadingShow less
Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Janet Morrison

Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Community Pharmacy England (CPE) chief executive Janet Morrison has welcomed chancellor Rachel Reeves announcement today that day-to-day spending on the NHS will increase by £29bn a year but insisted that it must reflect in securing the future of pharmacy.

Reeves also revealed that the government will be increasing the NHS technology budget by almost 50 per cent, with £10bn of investment to "bring our analogue health system into the digital age, including through the NHS app".

Keep ReadingShow less
Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less